Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20′-vinblastine congeners that lack antimicrotubule activity Linda S. BormanWilliam G. BornmannMartin E. Kuehne Original Articles Pages: 343 - 349
Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions K. -H. PflügerM. HahnK. Havemann Original Articles Pages: 350 - 356
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity E. E. VoestJ. P. NeijtJ. J. M. Marx Original Articles Pages: 357 - 362
Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer David C. SmithDuncan I. JodrellDonald L. Trump Original Articles Pages: 363 - 368
Effects of verapamil on the pharmacokinetics and metabolism of epirubicin K. MrossK. HammD. K. Hossfeld Original Articles Pages: 369 - 375
Development of a model of melphalan-induced gastrointestinal toxicity in mice Sharon CastellinoGertrude B. ElionHenry S. Friedman Original Articles Pages: 376 - 380
Cytotoxicity, DNA cross-linking, and DNA single-strand breaks induced by cyclophosphamide in a rat leukemia in vivo Ji-Yi WangGreg ProrokWilliam P. Vaughan Original Articles Pages: 381 - 386
Determination of the urinary excretion of ifosfamide and its phosphorated metabolites by phosphorus-31 nuclear magnetic resonance spectroscopy V. GilardM. C. Malet-MartinoR. Martino Original Articles Pages: 387 - 394
Phase I clinical study of LL-D49194α1 with retrospective pharmacokinetic investigations in mice and humans James CassidyMartin A. Grahamthe EORTC ECTG Original Articles Pages: 395 - 400
In vitro assessment ofN-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistance Graeme J. FinlayElaine MarshallBruce C. Baguley Original Articles Pages: 401 - 406
1-Dehydro-melengestrol acetate inhibitis the growth and protein kinase C activity of androgen-independent Dunning rat prostatic tumors Michael J. BattistoneGeorge M. PadillaVladimir Petrow Original Articles Pages: 407 - 411
Targeting chemosensitizing doses of toremifene based on protein binding Gregory T. WurzVernon D. EmshoffValerie J. Wiebe Short Communication Pages: 412 - 414
Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin Stephen P. LowisAndrew D. J. PearsonAlan W. Craft Short Communication Pages: 415 - 418
Phase II trial of the novel sulphonylurea sulofenur in advanced breast cancer Denis C. TalbotIan E. SmithJackie Walling Short Communication Pages: 419 - 422